title: P21 regulates TGF-beta1-induced pulmonary responses via a TNF-alpha-signaling pathway.
abstract: Transforming growth factor (TGF)-beta(1) is an essential regulatory cytokine that has been implicated in the pathogenesis of diverse facets of the injury and repair responses in the lung. The types of responses that it elicits can be appreciated in studies from our laboratory that demonstrated that the transgenic (Tg) overexpression of TGF-beta(1) in the murine lung causes epithelial apoptosis followed by fibrosis, inflammation, and parenchymal destruction. Because a cyclin-dependent kinase inhibitor, p21, is a key regulator of apoptosis, we hypothesized that p21 plays an important role in the pathogenesis of TGF-beta(1)-induced tissue responses. To test this hypothesis we evaluated the effect of TGF-beta(1) on the expression of p21 in the murine lung. We also characterized the effects of transgenic TGF-beta(1) in mice with wild-type and null mutant p21 loci. These studies demonstrate that TGF-beta(1) is a potent stimulator of p21 expression in the epithelial cells and macrophages in the murine lung. They also demonstrate that TGF-beta(1)-induced lung inflammation, fibrosis, myofibroblast accumulation, and alveolar destruction are augmented in the absence of p21, and that these alterations are associated with exaggerated levels of apoptosis and caspase-3 activation. Finally, our studies further demonstrated that TGF-beta(1) induces p21 via a TNF-alpha-signaling pathway and that p21 is a negative modulator of TGF-beta(1)-induced TNF-alpha expression. Collectively, our studies demonstrate that p21 regulates TGF-beta(1)-induced apoptosis, inflammation, fibrosis, and alveolar remodeling by interacting with TNF-alpha-signaling pathways.
authors.affiliation: Section of Pulmonary and Critical Care Medicine, Yale University School of Medicine, Department of Internal Medicine, 300 Cedar Street - S425A TAC, P.O. Box 208057, New Haven, CT 06520-8057, USA.
authors.forename: Masashi
authors.initials: M
authors.lastname: Yamasaki
authors.forename: Hye-Ryun
authors.initials: HR
authors.lastname: Kang
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Homer
authors.forename: Svetlana P
authors.initials: SP
authors.lastname: Chapoval
authors.forename: Soo Jung
authors.initials: SJ
authors.lastname: Cho
authors.forename: Byung Jae
authors.initials: BJ
authors.lastname: Lee
authors.forename: Jack A
authors.initials: JA
authors.lastname: Elias
authors.forename: Chun Geun
authors.initials: CG
authors.lastname: Lee
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D003433:Crosses, Genetic; D050759:Cyclin-Dependent Kinase Inhibitor p21 / Q000235:genetics / Q000502:physiology*; D004318:Doxycycline / Q000008:administration & dosage; D005355:Fibrosis / Q000139:chemically induced; D007150:Immunohistochemistry; D007249:Inflammation / Q000139:chemically induced; D008168:Lung / Q000473:pathology*; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D012333:RNA, Messenger / Q000032:analysis; D011897:Random Allocation; D015398:Signal Transduction; D013223:Statistics as Topic; D053773:Transforming Growth Factor beta1 / Q000032:analysis / Q000235:genetics / Q000378:metabolism / Q000633:toxicity*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
chemical_list: D050759:Cyclin-Dependent Kinase Inhibitor p21; D012333:RNA, Messenger; D053773:Transforming Growth Factor beta1; D014409:Tumor Necrosis Factor-alpha; D004318:Doxycycline